{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:06:01Z","timestamp":1790280361761,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1038\/s41397-026-00409-1","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T18:03:34Z","timestamp":1778004214000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["FTO rs7195994 Is associated with TNF inhibitor response in lean rheumatoid arthritis patients: A BMI-stratified pharmacogenetic analysis"],"prefix":"10.1038","volume":"26","author":[{"given":"Yi-Ting","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Chieh","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Wen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Mao","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Ju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Nan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7593-3065","authenticated-orcid":false,"given":"Yi-Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"409_CR1","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388:2023\u201338.","journal-title":"Lancet"},{"key":"409_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","volume":"46","author":"GS Firestein","year":"2017","unstructured":"Firestein GS, McInnes IB. Immunopathogenesis of rheumatoid arthritis. Immunity. 2017;46:183\u201396.","journal-title":"Immunity"},{"key":"409_CR3","doi-asserted-by":"publisher","first-page":"e0122088","DOI":"10.1371\/journal.pone.0122088","volume":"10","author":"G Avila-Pedretti","year":"2015","unstructured":"Avila-Pedretti G, Tornero J, Fern\u00e1ndez-Nebro A, Blanco F, Gonz\u00e1lez-Alvaro I, Ca\u00f1ete JD, et al. Variation at FCGR2A and functionally related genes is associated with the response to anti-TNF therapy in rheumatoid arthritis. PLoS ONE. 2015;10:e0122088.","journal-title":"PLoS ONE"},{"key":"409_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1136\/ard.2007.084715","volume":"68","author":"C Potter","year":"2009","unstructured":"Potter C, Hyrich KL, Tracey A, Lunt M, Plant D, Symmons DPM, et al. Association of rheumatoid factor and anti\u2013cyclic citrullinated peptide positivity, but not HLA-DRB1 status, with anti-TNF response in rheumatoid arthritis. Ann Rheum Dis. 2009;68:69\u201374.","journal-title":"Ann Rheum Dis"},{"key":"409_CR5","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.1093\/hmg\/ddn245","volume":"17","author":"JR Maxwell","year":"2008","unstructured":"Maxwell JR, Potter C, Hyrich KL, Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate, Barton A, Worthington J, et al. Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritis. Hum Mol Genet. 2008;17:3532\u20138.","journal-title":"Hum Mol Genet"},{"key":"409_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9","volume":"43","author":"JJ Anderson","year":"2000","unstructured":"Anderson JJ, Wells G, Verhoeven AC, Felson DT. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum. 2000;43:22\u201329.","journal-title":"Arthritis Rheum"},{"key":"409_CR7","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/ng.233","volume":"40","author":"S Raychaudhuri","year":"2008","unstructured":"Raychaudhuri S, Remmers EF, Lee AT, Hackett R, Guiducci C, Burtt NP, et al. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet. 2008;40:1216\u201323.","journal-title":"Nat Genet"},{"key":"409_CR8","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1136\/ard.2008.096982","volume":"68","author":"JD Ca\u00f1ete","year":"2009","unstructured":"Ca\u00f1ete JD, Su\u00e1rez B, Hern\u00e1ndez MV, Sanmart\u00ed R, Rego I, Celis R, et al. Influence of variants of Fc gamma receptors IIA and IIIA on the american college of rheumatology and european league against rheumatism responses to anti-tumour necrosis factor alpha therapy in rheumatoid arthritis. Ann Rheum Dis. 2009;68:1547\u201352.","journal-title":"Ann Rheum Dis"},{"key":"409_CR9","first-page":"1218","volume":"43","author":"A Zhernakova","year":"2011","unstructured":"Zhernakova A, Stahl EA, Trynka G, Raychaudhuri S, Festen EA, Franke L, et al. Meta-analysis of genome-wide association studies in rheumatoid arthritis reveals multiple new risk loci and links to autoimmunity. Nat Genet. 2011;43:1218\u201325.","journal-title":"Nat Genet"},{"key":"409_CR10","doi-asserted-by":"crossref","unstructured":"He S, Li W, Wang G, Wang X, Fan W, Zhang Z, et al. FTO-mediated m6A modification alleviates autoimmune uveitis by regulating microglia phenotypes via the GPC4\/TLR4\/NF-\u03baB signaling axis. Genes Dis. 2022;10:2179-93","DOI":"10.1016\/j.gendis.2022.09.008"},{"key":"409_CR11","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/ng.713","volume":"42","author":"C Church","year":"2010","unstructured":"Church C, Moir L, McMurray F, Girard C, Banks GT, Teboul L, et al. Overexpression of FTO leads to increased food intake and obesity in mice. Nat Genet. 2010;42:1086\u201392.","journal-title":"Nat Genet"},{"key":"409_CR12","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/cr.2014.151","volume":"24","author":"X Zhao","year":"2014","unstructured":"Zhao X, Yang Y, Sun BF, Shi Y, Yang X, Xiao W, et al. FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis. Cell Res. 2014;24:1403\u201319.","journal-title":"Cell Res"},{"key":"409_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1526475","volume":"16","author":"S Liu","year":"2025","unstructured":"Liu S, Li K, Long C, Lao M, Ma B, Liu C, et al. The role of FTO in m6A RNA methylation and immune regulation in staphylococcus aureus infection-related osteomyelitis. Front Microbiol. 2025;16:1526475.","journal-title":"Front Microbiol"},{"key":"409_CR14","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.7150\/ijbs.90677","volume":"20","author":"L Jin","year":"2024","unstructured":"Jin L, Chen Q, Hu K, Fan D, Zhang H, Deng J, et al. The FTO-CMPK2 pathway in fibroblast-like synoviocytes modulates rheumatoid arthritis synovial inflammation and cartilage homeostasis via mtDNA regulation. Int J Biol Sci. 2024;20:1617\u201333.","journal-title":"Int J Biol Sci"},{"key":"409_CR15","doi-asserted-by":"publisher","first-page":"1466023","DOI":"10.3389\/fimmu.2024.1466023","volume":"15","author":"Q Zhu","year":"2024","unstructured":"Zhu Q, Zhou H. The role of cGAS-STING signaling in rheumatoid arthritis: from pathogenesis to therapeutic targets. Front Immunol. 2024;15:1466023.","journal-title":"Front Immunol"},{"key":"409_CR16","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41397-018-0040-6","volume":"18","author":"J Massey","year":"2018","unstructured":"Massey J, Plant D, Hyrich K, Morgan AW, Wilson AG, Spiliopoulou A, et al. Genome-wide association study of response to tumour necrosis factor inhibitor therapy in rheumatoid arthritis. Pharmacogenomics J. 2018;18:657\u201364.","journal-title":"Pharmacogenomics J"},{"key":"409_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07606-z","volume":"16","author":"L Sun","year":"2025","unstructured":"Sun L, Zhang T, Ge Y, Yao Z, Su Y, Wang Q, et al. FTO controls CD8+ T cell survival and effector response by modulating m6A methylation of Fas. Cell Death Dis. 2025;16:301.","journal-title":"Cell Death Dis"},{"key":"409_CR18","doi-asserted-by":"crossref","unstructured":"Yang HC, Kwok PY, Li LH, Liu YM, Jong YJ, Lee KY, et al. The Taiwan precision medicine initiative: a cohort for large-scale studies. Nature. 2025;648:117\u2013127.","DOI":"10.1038\/s41586-025-09680-x"},{"key":"409_CR19","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European league against rheumatism collaborative initiative. Arthritis Rheum. 2010;62:2569\u201381.","journal-title":"Arthritis Rheum"},{"key":"409_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van \u2018t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL, et al. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:44\u201348.","journal-title":"Arthritis Rheum"},{"key":"409_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/art.1780390105","volume":"39","author":"AM van Gestel","year":"1996","unstructured":"van Gestel AM, Prevoo ML, van \u2018t Hof MA, van Rijswijk MH, van de Putte LB, et al. Development and validation of the european league against rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American college of rheumatology and the world health organization\/international league against rheumatism criteria. Arthritis Rheum. 1996;39:34\u201340.","journal-title":"Arthritis Rheum"},{"key":"409_CR22","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.3390\/genes12111711","volume":"12","author":"TT Yen","year":"2021","unstructured":"Yen TT, Chen IC, Hua MW, Wei CY, Shih KH, Li JL, et al. A KCNQ4 c.546C>G genetic variant associated with late onset non-syndromic hearing loss in a Taiwanese population. Genes. 2021;12:1711.","journal-title":"Genes"},{"key":"409_CR23","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2217\/14622416.9.2.235","volume":"9","author":"CT Fan","year":"2008","unstructured":"Fan CT, Lin JC, Lee CH. Taiwan biobank: a project aiming to aid Taiwan\u2019s transition into a biomedical island. Pharmacogenomics. 2008;9:235\u201346.","journal-title":"Pharmacogenomics"},{"key":"409_CR24","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559\u201375.","journal-title":"Am J Hum Genet"},{"key":"409_CR25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","volume":"363","author":"WHO Expert Consultation","year":"2004","unstructured":"WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157\u201363.","journal-title":"Lancet"},{"key":"409_CR26","first-page":"17","volume":"11","author":"TS Hung","year":"2022","unstructured":"Hung TS, Fox KR. Prevalence of overweight and obesity in Taiwanese adults: estimates from national surveys, 1990\u20132017. Journal of Medicine and Health (in Chinese). 2022;11:17\u201332.","journal-title":"Journal of Medicine and Health (in Chinese)"},{"key":"409_CR27","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1097\/CM9.0000000000003904","volume":"138","author":"Y Xiao","year":"2025","unstructured":"Xiao Y, Ma Y, Zhao J, Zhang X, Gan C, Gao J, et al. The cGAS-STING signaling pathway as a therapeutic target in human diseases. Chin Med J. 2025;138:3251\u201384.","journal-title":"Chin Med J"},{"key":"409_CR28","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1111\/1756-185X.13607","volume":"22","author":"J Polo y La Borda","year":"2019","unstructured":"Polo y La Borda J, Campos J, Sanz J, Andr\u00e9u JL, Mulero J, S\u00e1nchez A, et al. Predictive clinical-genetic model of long-term non-response to tumor necrosis factor-alpha inhibitor therapy in spondyloarthritis. Int J Rheum Dis. 2019;22:1529\u201337.","journal-title":"Int J Rheum Dis"},{"key":"409_CR29","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/16852","volume":"397","author":"YY Kong","year":"1999","unstructured":"Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 1999;397:315\u201323.","journal-title":"Nature"},{"key":"409_CR30","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/ard.2011.149765","volume":"70","author":"DT Felson","year":"2011","unstructured":"Felson DT, Smolen JS, Wells G, Zhang B, van Tuyl LH, Funovits J, et al. American college of Rheumatology\/European league against rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis. 2011;70:404\u201313.","journal-title":"Ann Rheum Dis"},{"key":"409_CR31","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/art.30130","volume":"63","author":"D Plant","year":"2011","unstructured":"Plant D, Bowes J, Potter C, Hyrich KL, Morgan AW, Wilson AG, et al. Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci. Arthritis Rheum. 2011;63:645\u201353.","journal-title":"Arthritis Rheum"},{"key":"409_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/art.22331","volume":"56","author":"KL Hyrich","year":"2007","unstructured":"Hyrich KL, Lunt M, Watson KD, Symmons DP, Silman AJ, British Society for Rheumatology Biologics Register. et al. Outcomes after switching from one anti-tumor necrosis factor alpha agent to a second anti-tumor necrosis factor alpha agent in patients with rheumatoid arthritis: results from a large UK national cohort study. Arthritis Rheum. 2007;56:13\u201320.","journal-title":"Arthritis Rheum"},{"key":"409_CR33","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/ard.2009.123919","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010;69:631\u20137.","journal-title":"Ann Rheum Dis"},{"key":"409_CR34","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/S0140-6736(99)05246-0","volume":"354","author":"R Maini","year":"1999","unstructured":"Maini R, St Clair EW, Breedveld F, Furst D, Kalden J, Weisman M, et al. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. Lancet. 1999;354:1932\u20139.","journal-title":"Lancet"},{"key":"409_CR35","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1093\/rheumatology\/kel149","volume":"45","author":"KL Hyrich","year":"2006","unstructured":"Hyrich KL, Watson KD, Silman AJ, Symmons DP, British Society for Rheumatology Biologics Register. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British society for rheumatology biologics register. Rheumatology (Oxford). 2006;45:1558\u201365.","journal-title":"Rheumatology (Oxford)"},{"key":"409_CR36","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1136\/ard.61.8.718","volume":"61","author":"F Buttgereit","year":"2002","unstructured":"Buttgereit F, da Silva JA, Boers M, Burmester GR, Cutolo M, Jacobs J, et al. Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology. Ann Rheum Dis. 2002;61:718\u201322.","journal-title":"Ann Rheum Dis"},{"key":"409_CR37","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.1007\/s12325-023-02607-w","volume":"40","author":"V Rosenberg","year":"2023","unstructured":"Rosenberg V, Chodick G, Xue Z, Faccin F, Amital H. Real-world data of adherence and drug survival of biologics in treatment-na\u00efve and treatment-experienced adult patients with rheumatoid arthritis. Adv Ther. 2023;40:4504\u201322.","journal-title":"Adv Ther"},{"key":"409_CR38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrrheum.2016.200","volume":"13","author":"AI Catrina","year":"2017","unstructured":"Catrina AI, Svensson CI, Malmstr\u00f6m V, Schett G, Klareskog L. Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis. Nat Rev Rheumatol. 2017;13:79\u201386.","journal-title":"Nat Rev Rheumatol"}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41397-026-00409-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41397-026-00409-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41397-026-00409-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T06:12:24Z","timestamp":1782195144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41397-026-00409-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["409"],"URL":"https:\/\/doi.org\/10.1038\/s41397-026-00409-1","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"value":"1470-269X","type":"print"},{"value":"1473-1150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"14 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This retrospective study was approved by the Institutional Review Board of Taichung Veterans General Hospital (IRB number: CF21176A). All methods were performed in accordance with the Declaration of Helsinki. The requirement for informed consent was waived due to the use of de-identified data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"20"}}